If I give a woman with breast cancer a drug called Taxol every three weeks, which is the standard, about 40 percent of women with metastatic cancer have a great response to that drug.
Se se lle dá Taxol a unha muller con cancro de mama, cada tres semanas, que é o habitual, ata un 40% das mulleres con metástase responden a ese medicamento de maneira satisfactoria: